The clinical outcomes of the newer weekly medications are also, in most cases, superior
Medication can directly compete with micronutrients when they use the same metabolic and transport pathways, modifying the pharmacokinetics or micronutrient status [18,19,20] (absorption, distribution, metabolism, excretion) [21]
Thberge J, Al-Semaan Y, Jensen JE, Williamson PC, Neufeld RW, Menon RS, et al
About the review This review aims to simultaneously promote GLP-1 RA research and enhance users' understanding by synthesizing evidence from recent landmark trials, thereby providing a comprehensive picture of the potential of these drugs as more than just metabolic modulators
Furthermore, this novel concept suggests that the GLP-1 analog could spare the pasireotide-induced decrease in endogenous GLP-1 concentrations and recover insulin secretion suppressed by pasireotide through GLP-1R-Gs activation counteracting the SSTRs-Gi axis
Who Should Take Tesamorelin